| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 94ZLA3W45F |
| Parent Compound: | ARGININE |
| InChI Key | ODKSFYDXXFIFQN-BYPYZUCNSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C6H14N4O2 |
| Molecular Weight | 174.2 |
| AlogP | -1.34 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 125.22 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 12.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | - | - | - | 4 | |
|
Enzyme
|
- | - | 7000-7000 | - | 4 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC03 and SLC07 families of heteromeric amino acid transporters (HATs)
SLC07 Cationic amino acid transporter/glycoprotein-associated family
|
- | - | - | - | 49-49 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Anemia, Sickle Cell | 3 | D000755 | ClinicalTrials |
| Pre-Eclampsia | 3 | D011225 | ClinicalTrials |
| Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
| Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
| Tuberculosis, Pulmonary | 3 | D014397 | ClinicalTrials |
| Hypersensitivity | 3 | D006967 | ClinicalTrials |
| Glucose Intolerance | 3 | D018149 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| MELAS Syndrome | 2 | D017241 | ClinicalTrials |
| beta-Thalassemia | 2 | D017086 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
| Death, Sudden, Cardiac | 2 | D016757 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
| Pain | 2 | D010146 | ClinicalTrials |
| Asthma | 2 | D001249 | ClinicalTrials |
| Galactosemias | 2 | D005693 | ClinicalTrials |
| Malaria, Falciparum | 2 | D016778 | ClinicalTrials |
| Hepatitis, Alcoholic | 2 | D006519 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Lymphoma | 2 | D008223 | ClinicalTrials |
| Dental Caries | 2 | D003731 | ClinicalTrials |
| Aortic Aneurysm, Abdominal | 2 | D017544 | ClinicalTrials |
| Hernias, Diaphragmatic, Congenital | 2 | D065630 | ClinicalTrials |
| Essential Hypertension | 2 | D000075222 | ClinicalTrials |
| Sepsis | 2 | D018805 | ClinicalTrials |
| Argininosuccinic Aciduria | 2 | D056807 | ClinicalTrials |
| Muscular Dystrophy, Duchenne | 1 | D020388 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Liver Cirrhosis | 1 | D008103 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Hypertension | 1 | D006973 | ClinicalTrials |
| Coronary Disease | 1 | D003327 | ClinicalTrials |
| Heart Failure | 1 | D006333 | ClinicalTrials |
| Kidney Diseases | 0 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 74-79-3 |
| ChEBI | 16467 |
| ChEMBL | CHEMBL1485 |
| DrugBank | DB00125 |
| DrugCentral | 1549 |
| EPA CompTox | DTXSID6041056 |
| FDA SRS | 94ZLA3W45F |
| Human Metabolome Database | HMDB0000517 |
| Guide to Pharmacology | 721 |
| KEGG | C00062 |
| PharmGKB | PA448478 |
| PubChem | 6322 |
| SureChEMBL | SCHEMBL1791 |
| ZINC | ZINC000001532525 |